Identification of Evi-1 as a novel effector of PKCδ in the apoptotic response to DNA damage

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1809, Issue 7, 2011, Pages 285-294

  Hew, Hoi Chin ^a   Liu, Hanshao ^a   Lu, Zheng Guang ^a   Kimura, Junko ^a   Miki, Yoshio ^a   Yoshida, Kiyotsugu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; DNA damage; Evi 1; PKC ; PLZF

Indexed keywords

PROTEIN KINASE C DELTA;

APOPTOSIS; ARTICLE; CELL DEATH; DNA DAMAGE; EFFECTOR CELL; GENE IDENTIFICATION; GENOTOXICITY; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; TRANSACTIVATION; TRANSCRIPTION REGULATION;

APOPTOSIS; CELL LINE, TUMOR; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PROTEIN KINASE C-DELTA; PROTO-ONCOGENES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 79960731554     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2011.02.004     Document Type: Article

References (49)

1. Gschwendt M. Protein kinase C delta. Eur. J. Biochem. 1999, 259:555-564.
2. Li W., Mischak H., Yu J.C., Wang L.M., Mushinski J.F., Heidaran M.A., Pierce J.H. Tyrosine phosphorylation of protein kinase C-delta in response to its activation. J. Biol. Chem. 1994, 269:2349-2352.
3. Jackson D.N., Foster D.A. The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival. FASEB J. 2004, 18:627-636.
4. Steinberg S.F. Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochem. J. 2004, 384:449-459.
5. Emoto Y., Manome Y., Meinhardt G., Kisaki H., Kharbanda S., Robertson M., Ghayur T., Wong W.W., Kamen R., Weichselbaum R., et al. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J. 1995, 14:6148-6156.
6. Ghayur T., Hugunin M., Talanian R.V., Ratnofsky S., Quinlan C., Emoto Y., Pandey P., Datta R., Huang Y., Kharbanda S., Allen H., Kamen R., Wong W., Kufe D. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med. 1996, 184:2399-2404.
7. Yuan Z.M., Utsugisawa T., Ishiko T., Nakada S., Huang Y., Kharbanda S., Weichselbaum R., Kufe D. Activation of protein kinase C delta by the c-Abl tyrosine kinase in response to ionizing radiation. Oncogene 1998, 16:1643-1648.
8. Sun X., Wu F., Datta R., Kharbanda S., Kufe D. Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J. Biol. Chem. 2000, 275:7470-7473.
9. Bharti A., Kraeft S.K., Gounder M., Pandey P., Jin S., Yuan Z.M., Lees-Miller S.P., Weichselbaum R., Weaver D., Chen L.B., Kufe D., Kharbanda S. Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. Mol. Cell. Biol. 1998, 18:6719-6728.
10. Liu J., Chen J., Dai Q., Lee R.M. Phospholipid scramblase 3 is the mitochondrial target of protein kinase C delta-induced apoptosis. Cancer Res. 2003, 63:1153-1156.
11. Cross T., Griffiths G., Deacon E., Sallis R., Gough M., Watters D., Lord J.M. PKC-delta is an apoptotic lamin kinase. Oncogene 2000, 19:2331-2337.
12. Yoshida K., Wang H.G., Miki Y., Kufe D. Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9. EMBO J. 2003, 22:1431-1441.
13. Yoshida K., Liu H., Miki Y. Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J. Biol. Chem. 2006, 281:5734-5740.
14. Yamaguchi T., Miki Y., Yoshida K. Protein kinase C delta activates IkappaB-kinase alpha to induce the p53 tumor suppressor in response to oxidative stress. Cell. Signal. 2007, 19:2088-2097.
15. Liu H., Lu Z.G., Miki Y., Yoshida K. Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage. Mol. Cell. Biol. 2007, 27:8480-8491.
16. Takahashi S., Licht J.D. The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein. Leukemia 2002, 16:1755-1762.
17. Yoshida K., Kufe D. Negative regulation of the SHPTP1 protein tyrosine phosphatase by protein kinase C delta in response to DNA damage. Mol. Pharmacol. 2001, 60:1431-1438.
18. Yoshida K., Yamaguchi T., Shinagawa H., Taira N., Nakayama K.I., Miki Y. Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage. Mol. Cell. Biol. 2006, 26:3414-3431.
19. Yoshida K., Kharbanda S., Kufe D. Functional interaction between SHPTP1 and the Lyn tyrosine kinase in the apoptotic response to DNA damage. J. Biol. Chem. 1999, 274:34663-34668.
20. Yoshida K., Miki Y., Kufe D. Activation of SAPK/JNK signaling by protein kinase Cdelta in response to DNA damage. J. Biol. Chem. 2002, 277:48372-48378.
21. Yamaguchi T., Kimura J., Miki Y., Yoshida K. The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha). J. Biol. Chem. 2007, 282:33943-33948.
22. Kimura J., Nguyen S.T., Liu H., Taira N., Miki Y., Yoshida K. A functional genome-wide RNAi screen identifies TAF1 as a regulator for apoptosis in response to genotoxic stress. Nucleic Acids Res. 2008, 36:5250-5259.
23. Morishita K., Suzukawa K., Taki T., Ihle J.N., Yokota J. EVI-1 zinc finger protein works as a transcriptional activator via binding to a consensus sequence of GACAAGATAAGATAAN1-28 CTCATCTTC. Oncogene 1995, 10:1961-1967.
24. P. Collas, The current state of chromatin immunoprecipitation, Mol Biotechnol, 45:87-100.
25. Morishita K., Parker D.S., Mucenski M.L., Jenkins N.A., Copeland N.G., Ihle J.N. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 1988, 54:831-840.
26. Buonamici S., Chakraborty S., Senyuk V., Nucifora G. The role of EVI1 in normal and leukemic cells. Blood Cells Mol. Dis. 2003, 31:206-212.
27. Mitani K., Ogawa S., Tanaka T., Miyoshi H., Kurokawa M., Mano H., Yazaki Y., Ohki M., Hirai H. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 1994, 13:504-510.
28. Goyama S., Yamamoto G., Shimabe M., Sato T., Ichikawa M., Ogawa S., Chiba S., Kurokawa M. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell 2008, 3:207-220.
29. Hoyt P.R., Bartholomew C., Davis A.J., Yutzey K., Gamer L.W., Potter S.S., Ihle J.N., Mucenski M.L. The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech. Dev. 1997, 65:55-70.
30. Kazama H., Kodera T., Shimizu S., Mizoguchi H., Morishita K. Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation. Cell Growth Differ. 1999, 10:565-573.
31. Buonamici S., Li D., Chi Y., Zhao R., Wang X., Brace L., Ni H., Saunthararajah Y., Nucifora G. EVI1 induces myelodysplastic syndrome in mice. J. Clin. Invest. 2004, 114:713-719.
32. Konrad T.A., Karger A., Hackl H., Schwarzinger I., Herbacek I., Wieser R. Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes. J. Leukoc. Biol. 2009, 86:813-822.
33. Roy P., Reavey E., Rayne M., Roy S., Abed El Baky M., Ishii Y., Bartholomew C. Enhanced sensitivity to hydrogen peroxide-induced apoptosis in Evi1 transformed Rat1 fibroblasts due to repression of carbonic anhydrase III. FEBS J. 2009, 277:441-452.
34. Chen Z., Brand N.J., Chen A., Chen S.J., Tong J.H., Wang Z.Y., Waxman S., Zelent A. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 1993, 12:1161-1167.
35. Parrado A., Chomienne C., Padua R.A. Retinoic acid receptor alpha (RAralpha) mutations in human leukemia. Leuk. Lymphoma 2000, 39:271-282.
36. Yeyati P.L., Shaknovich R., Boterashvili S., Li J., Ball H.J., Waxman S., Nason-Burchenal K., Dmitrovsky E., Zelent A., Licht J.D. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 1999, 18:925-934.
37. Costoya J.A., Hobbs R.M., Barna M., Cattoretti G., Manova K., Sukhwani M., Orwig K.E., Wolgemuth D.J., Pandolfi P.P. Essential role of Plzf in maintenance of spermatogonial stem cells. Nat. Genet. 2004, 36:653-659.
38. Buaas F.W., Kirsh A.L., Sharma M., McLean D.J., Morris J.L., Griswold M.D., de Rooij D.G., Braun R.E. Plzf is required in adult male germ cells for stem cell self-renewal. Nat. Genet. 2004, 36:647-652.
39. Barna M., Merghoub T., Costoya J.A., Ruggero D., Branford M., Bergia A., Samori B., Pandolfi P.P. Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. Dev. Cell 2002, 3:499-510.
40. Costoya J.A., Pandolfi P.P. The role of promyelocytic leukemia zinc finger and promyelocytic leukemia in leukemogenesis and development. Curr. Opin. Hematol. 2001, 8:212-217.
41. Barna M., Hawe N., Niswander L., Pandolfi P.P. Plzf regulates limb and axial skeletal patterning. Nat. Genet. 2000, 25:166-172.
42. Felicetti F., Bottero L., Felli N., Mattia G., Labbaye C., Alvino E., Peschle C., Colombo M.P., Care A. Role of PLZF in melanoma progression. Oncogene 2004, 23:4567-4576.
43. Parrado A., Noguera M.E., Delmer A., McKenna S., Davies J., Le Gall I., Bentley P., Whittaker J.A., Sigaux F., Chomienne C., Padua R.A. Deregulated expression of promyelocytic leukemia zinc finger protein in B-cell chronic lymphocytic leukemias does not affect cyclin A expression. Hematol. J. 2000, 1:15-27.
44. Cheung M., Pei J., Pei Y., Jhanwar S.C., Pass H.I., Testa J.R. The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival. Oncogene 2009.
45. Shaknovich R., Yeyati P.L., Ivins S., Melnick A., Lempert C., Waxman S., Zelent A., Licht J.D. The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol. Cell. Biol. 1998, 18:5533-5545.
46. McConnell M.J., Chevallier N., Berkofsky-Fessler W., Giltnane J.M., Malani R.B., Staudt L.M., Licht J.D. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Mol. Cell. Biol. 2003, 23:9375-9388.
47. Bernardo M.V., Yelo E., Gimeno L., Campillo J.A., Parrado A. Identification of apoptosis-related PLZF target genes. Biochem. Biophys. Res. Commun. 2007, 359:317-322.
48. Chakraborty S., Senyuk V., Sitailo S., Chi Y., Nucifora G. Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles. J. Biol. Chem. 2001, 276:44936-44943.
49. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.